REGENERON PHARMACEUTICALS (REGN) Stock Earnings & Estimates
USA - NASDAQ:REGN - US75886F1075 - Common Stock
654.48 USD
+69.17 (+11.82%)
650 USD
-4.48 (-0.68%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12.173B -24.26% | 13.117B 7.76% | 14.202B 8.27% | 14.136B -0.46% | 14.846B 5.02% | 16.43B 10.67% | 17.584B 7.02% | 18.652B 6.07% | 19.536B 4.74% | 20.042B 2.59% | 19.734B -1.54% | |
| EBITDA YoY % growth | 5.594B -41.17% | 4.757B -14.97% | 4.701B -1.17% | 4.575B -2.68% | 5.252B 14.80% | 6.028B 14.78% | 7.098B 17.75% | 7.591B 6.95% | 8.018B 5.63% | 8.418B 4.99% | 6.732B -20.03% | |
| EBIT YoY % growth | 5.253B -43.04% | 4.336B -17.46% | 4.218B -2.71% | 4.372B 3.65% | 4.785B 9.45% | 5.89B 23.09% | 6.455B 9.59% | 7.096B 9.93% | 7.728B 8.91% | 7.997B 3.48% | 7.655B -4.28% | |
| Operating Margin | 43.15% | 33.05% | 29.70% | 30.93% | 32.23% | 35.85% | 36.71% | 38.04% | 39.56% | 39.90% | 38.79% | |
| EPS YoY % growth | 42.40 -40.60% | 43.78 3.25% | 45.64 4.25% | 40.02 -12.32% | 42.01 4.99% | 50.59 20.41% | 55.38 9.47% | 60.52 9.28% | 65.58 8.36% | 69.48 5.95% | 67.61 -2.70% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 9.59 -20.51% | 9.52 15.79% | 11.20 -13.09% | 11.29 -4.60% | 11.12 15.90% | 9.68 1.70% | 14.80 32.11% | 11.96 6.02% | 11.96 7.59% |
| Revenue Q2Q % growth | 3.72B -1.83% | 3.402B 12.31% | 3.692B 0.45% | 3.845B 2.42% | 3.887B 4.49% | 3.491B 2.62% | 4.021B 8.91% | 3.944B 2.57% | 3.998B 2.86% |
| EBITDA Q2Q % growth | 1.117B -30.76% | 1.195B 63.50% | 1.549B 14.61% | 1.519B 24.00% | 1.429B 27.93% | 1.144B -4.27% | 1.695B 9.43% | 1.439B -5.27% | 1.433B 0.28% |
| EBIT Q2Q % growth | 1.024B -9.40% | 1.031B 70.70% | 1.274B 16.93% | 1.268B 14.44% | 1.237B 20.80% | 1.015B -1.55% | 1.557B 22.21% | 1.315B 3.71% | 1.304B 5.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 11.83 -5.06% | 9.78 | 2.05 | 20.96% |
| Q2 2025 Q2Q % growth | 12.89 11.51% | 8.61 | 4.28 | 49.77% |
| Q1 2025 Q2Q % growth | 8.22 -13.93% | 9.00 | -0.78 | -8.66% |
| Q4 2024 Q2Q % growth | 12.07 1.77% | 11.50 | 0.57 | 4.93% |
| Q3 2024 Q2Q % growth | 12.46 7.51% | 11.93 | 0.53 | 4.48% |
| Q2 2024 Q2Q % growth | 11.56 12.89% | 10.83 | 0.73 | 6.79% |
| Q1 2024 Q2Q % growth | 9.55 -5.35% | 10.29 | -0.74 | -7.23% |
| Q4 2023 Q2Q % growth | 11.86 -5.57% | 10.95 | 0.91 | 8.36% |
| Q3 2023 Q2Q % growth | 11.59 4.04% | 10.93 | 0.66 | 6.01% |
| Q2 2023 Q2Q % growth | 10.24 4.81% | 10.04 | 0.20 | 1.99% |
| Q1 2023 Q2Q % growth | 10.09 12.99% | 9.75 | 0.34 | 3.50% |
| Q4 2022 Q2Q % growth | 12.56 -41.09% | 10.23 | 2.33 | 22.77% |
| Q3 2022 Q2Q % growth | 11.14 -22.48% | 9.67 | 1.47 | 15.25% |
| Q2 2022 Q2Q % growth | 9.77 -62.13% | 9.02 | 0.75 | 8.33% |
| Q1 2022 Q2Q % growth | 8.93 -9.71% | 9.93 | -1.00 | -10.09% |
| Q4 2021 Q2Q % growth | 21.32 123.71% | 18.71 | 2.61 | 13.93% |
| Q3 2021 Q2Q % growth | 14.37 71.89% | 10.31 | 4.06 | 39.43% |
| Q2 2021 Q2Q % growth | 25.80 260.34% | 17.88 | 7.92 | 44.32% |
| Q1 2021 Q2Q % growth | 9.89 49.85% | 9.18 | 0.71 | 7.72% |
| Q4 2020 Q2Q % growth | 9.53 27.07% | 8.56 | 0.97 | 11.32% |
| Q3 2020 Q2Q % growth | 8.36 25.34% | 7.28 | 1.08 | 14.87% |
| Q2 2020 Q2Q % growth | 7.16 18.94% | 6.10 | 1.06 | 17.32% |
| Q1 2020 Q2Q % growth | 6.60 48.31% | 6.25 | 0.35 | 5.53% |
| Q4 2019 Q2Q % growth | 7.50 | 7.04 | 0.46 | 6.46% |
| Q3 2019 Q2Q % growth | 6.67 | 6.49 | 0.18 | 2.79% |
| Q2 2019 Q2Q % growth | 6.02 | 5.52 | 0.50 | 9.15% |
| Q1 2019 Q2Q % growth | 4.45 | 5.58 | -1.13 | -20.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 3.754B 0.90% | 3.657B | 97.3M | 2.66% |
| Q2 2025 Q2Q % growth | 3.676B 3.62% | 3.35B | 325.6M | 9.72% |
| Q1 2025 Q2Q % growth | 3.029B -3.69% | 3.34B | -311M | -9.31% |
| Q4 2024 Q2Q % growth | 3.789B 10.34% | 3.824B | -34.8M | -0.91% |
| Q3 2024 Q2Q % growth | 3.721B 10.65% | 3.744B | -23.3M | -0.62% |
| Q2 2024 Q2Q % growth | 3.547B 12.32% | 3.446B | 101.1M | 2.93% |
| Q1 2024 Q2Q % growth | 3.145B -0.54% | 3.284B | -139M | -4.23% |
| Q4 2023 Q2Q % growth | 3.434B 0.57% | 3.351B | 83M | 2.48% |
| Q3 2023 Q2Q % growth | 3.363B 14.53% | 3.298B | 64.7M | 1.96% |
| Q2 2023 Q2Q % growth | 3.158B 10.53% | 3.077B | 81.1M | 2.64% |
| Q1 2023 Q2Q % growth | 3.162B 6.64% | 3.06B | 102.1M | 3.34% |
| Q4 2022 Q2Q % growth | 3.414B -31.05% | 3.188B | 226.4M | 7.10% |
| Q3 2022 Q2Q % growth | 2.936B -14.96% | 2.926B | 10.2M | 0.35% |
| Q2 2022 Q2Q % growth | 2.857B -44.40% | 2.852B | 5.2M | 0.18% |
| Q1 2022 Q2Q % growth | 2.965B 17.26% | 2.779B | 186.1M | 6.70% |
| Q4 2021 Q2Q % growth | 4.952B 104.37% | 4.598B | 353.7M | 7.69% |
| Q3 2021 Q2Q % growth | 3.453B 50.51% | 2.873B | 579.8M | 20.18% |
| Q2 2021 Q2Q % growth | 5.139B 163.24% | 3.995B | 1.144B | 28.62% |
| Q1 2021 Q2Q % growth | 2.529B 38.32% | 2.602B | -73.3M | -2.82% |
| Q4 2020 Q2Q % growth | 2.423B 11.68% | 2.471B | -48.1M | -1.95% |
| Q3 2020 Q2Q % growth | 2.294B 31.56% | 2.13B | 164M | 7.70% |
| Q2 2020 Q2Q % growth | 1.952B 23.72% | 1.777B | 175M | 9.85% |
| Q1 2020 Q2Q % growth | 1.828B 33.19% | 1.793B | 35.2M | 1.96% |
| Q4 2019 Q2Q % growth | 2.17B | 2.143B | 26.5M | 1.24% |
| Q3 2019 Q2Q % growth | 1.744B | 2.026B | -282.3M | -13.93% |
| Q2 2019 Q2Q % growth | 1.578B | 1.838B | -260.2M | -14.16% |
| Q1 2019 Q2Q % growth | 1.373B | 1.796B | -423.4M | -23.57% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.22% | 4.26% | 0.53% | 10.86% |
| Revenue | 0.55% | 4.58% | 0.01% | 3.58% |